Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:6/30/2009

Second Quarter 2009 Earnings Conference Call Tuesday, August 4, 2009, 5:00 p.m. U.S. EDT

FRAZER, Pa., June 30 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering second quarter 2009 results for 5:00 p.m. EDT on Tuesday, August 4, 2009.

August 4, 2009 Schedule

    4:10 p.m. EDT   Q2 2009 results will be distributed by PRNewswire
    4:50 p.m. EDT   To participate in the conference call, dial 913-312-0379
                    and refer to Conference Code Number 1696714

    5:00 p.m. EDT   Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on the "Investors" tab then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EDT, August 11, 2009. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 1696714.

Additional information presented on the conference call may be made available on the Investor page of the company's website.

    Contact: Robert S. (Chip) Merritt
    610-738-6376
    cmerritt@cephalon.com


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
2. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
3. Cephalons New Product Launches Pace Record 2008 Sales
4. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
5. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
6. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
7. Cephalon, Inc. to Webcast Analyst Day
8. Cephalon Reports Another Strong Quarter
9. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
10. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
11. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...wswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC )...rd quarter ended September 30, 2009. GenVec report...r the three months ended September 30, 2009 compar... in the comparable quarter of 2008. For the nine m...was $14.1 million ($0.15 per share), compared to a...
(Date:11/5/2009)...vember 5, 2009 at 4:30 p.m. Eastern Time , BO...ll/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex"... unaudited financial results for the third quarter...ewed the Company,s highlights for the third quarte...s reflect the operations of OncoGenex Technologies...
(Date:11/5/2009)... Senomyx, Inc. (Nasdaq: ...ste receptor-based technologies to discover novel ...redient supply industries, today provided a corpor...third quarter ended September 30, 2009. Revenues ...ompared to $4.0 million for the third quarter of 2...
(Date:11/5/2009)...ry and vision correction experts listed in the Tru...ed at the recently concluded American Academy of O...cisco, California. Dr. Stephen Brint, MD, Dr. Fred...Dr. Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr....Edward Manche, MD, and Dr. Parag Majmudar, MD, all...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...irstCall/ - Quest PharmaTech Inc.,("Quest" or the ...llaborative research agreement with the BC Cancer ...py for the treatment of lung cancer. The,potential...y product,SL052, with various immunotherapeutic ag... (PDT) can augment the therapeutic effects of,immu...
...onfirmed today that,entities affiliated with him h...o nominate three persons at Biogen,s forthcoming 2...ectors of Biogen. Biogen currently,has a staggered...ectorships,up for election this year., Mr. Icahn ...believe,that Biogen,s recent purported attempt to ...
...ura Therapeutics Inc., an,early stage biotechnolog...cently completed a successful Investigational New ...dministration (FDA). The IND enables Velcura to,pr...s lead compound,VEL-0230., VEL-0230 is a new chem...at it both stimulates bone formation and inhibits ...
Other Biology Technology:Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3Icahn Confirms Intention to Nominate Three Directors at Biogen 2Icahn Confirms Intention to Nominate Three Directors at Biogen 3Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA 2
(Date:11/5/2009)...y Teachers (NABT) will recognize Leonard C. Yannie... Valley Community College (NVCC) in Waterbury, Con...during the NABT annual professional development co... Colorado. , The Evolution Education Award is co...Sciences,(AIBS) and Biological Sciences Curriculu...
(Date:11/4/2009)...ence) , United States Using Less Water Today ...t did 35 years ago, despite a 30 percent populatio...butable to alternative cooling methods at power pl...ing to the latest USGS water use report, nearly ha...cooling thermoelectric power plants. Irrigation ac...
(Date:11/4/2009)...phered the DNA codes, or genomes, of the famed fug...he Genome 10K Project, an international effort to ... 10,000 species of animals for conducting comparat...chieved. , Participating in The Genome 10K proje...2009 issue of the Journal of Heredity , are 70 le...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2Conceptual Options a Center for Surrogacy 26amp 3B Egg Donation Announces Third Party Assurance Program 47863 1Conceptual Options a Center for Surrogacy 26amp 3B Egg Donation Announces Third Party Assurance Program 47863 2Conceptual Options a Center for Surrogacy 26amp 3B Egg Donation Announces Third Party Assurance Program 47863 3Illness medical bills linked to nearly two thirds of bankruptcies 47858 1Illness medical bills linked to nearly two thirds of bankruptcies 47858 2Illness medical bills linked to nearly two thirds of bankruptcies 47858 3Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute 12458 1Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute 12458 2
...s have devised a tool to help understand and predi... 70,000 nucleosomes in yeast. Nucleosomes wrap DNA...itical indicators and regulators of a cells state....sor with the Banting and Best Department of Medica...he team created a complete, three-dimensional map ...
...gns of the oceans matters increasingly to the well...ip of international scientists urging support to c... years. , The Partnership for Observation of the ...ng and pollution are among profound concerns that ... a well-informed, timely and cost-effective way. ,...
...ck there. Farmers may find phytochemicals to be th...n the bucket that cashes in on the tug-o-war betwe...h by the Texas Agricultural Experiment Station. , ...tables in the farm patch increases disease-prevent...ers may one day pay a premium, scientists say. , ...
Other Biology News:Human safety, prosperity depend on better ocean observing system: Scientists 2Human safety, prosperity depend on better ocean observing system: Scientists 3Human safety, prosperity depend on better ocean observing system: Scientists 4Human safety, prosperity depend on better ocean observing system: Scientists 5Human safety, prosperity depend on better ocean observing system: Scientists 6Human safety, prosperity depend on better ocean observing system: Scientists 7Human safety, prosperity depend on better ocean observing system: Scientists 8Old McDonald had a phytochemical 2Old McDonald had a phytochemical 3
...Protein DetectorTM Microarray Dot Blot Kits overco...uracy and quantitation over a wide range in low-de...tection. They are ideal for performing reverse-ph...amples for the presence of low abundant antigens. ...
...Convenient, easy-to-use kits for arraying proteins...tion using common lab equipment. DiscoverLight Pro...ur protein, cell lysate or antibody in a low-densi...ed nitrocellulose membranes with a 384-grid templa...
Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
...StabilZyme AP Conjugate Stabilizer is an aqueous s...d other non-toxic stabilizing chemicals in a MES b...6.5. This product contains a combination of 0.02%...s a preservative. StabilZyme AP Conjugate Stabili...
Biology Products: